2015 Quality Performance Results

Measure NumberMeasure Name2015 Reporting Period
ACO Performance RateMean Performance Rate (SSP – ACOs)
ACO-1CAHPS: Getting Timely Care, Appointments, and Information80.6380.61
ACO-2CAHPS: How Well Your Providers Communicate93.4392.65
ACO-3CAHPS: Patients’ Rating of Provider92.8391.94
ACO-4CAHPS: Access to Specialists85.2183.61
ACO-5CAHPS: Health Promotion and Education58.959.06
ACO-6CAHPS: Shared Decision Making74.1975.17
ACO-7CAHPS: Health Status/Functional Status74.6572.3
ACO-34CAHPS: Stewardship of Patient Resources*29.726.87
ACO-8Risk Standardized, All Condition Readmission14.4614.86
ACO-35Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission19.3518.07
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes*44.1454.6
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure*71.8776.96
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions57.1562.92
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)0.951.11
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)1.171.04
ACO-11Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements93.18%76.22%
ACO-39Documentation of Current Medications in the Medical Record*99.04%84.07%
ACO-13Falls: Screening for Future Fall Risk77.64%56.46%
ACO-14Preventive Care and Screening: Influenza Immunization26.32%62.03%
ACO-15Pneumonia Vaccination Status for Older Adults44.56%63.73%
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up77.53%71.15%
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention93.04%90.16%
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan21.12%45.25%
ACO-19Colorectal Cancer Screening44.33%60.06%
ACO-20Breast Cancer Screening27.70%65.67%
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented59.13%70.04%
ACO-40Depression Remission at Twelve Months*N/AN/A
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control99.82%20.38%
ACO-41Diabetes: Eye Exam*12.16%41.05%
ACO-28Hypertension: Controlling High Blood Pressure67.10%69.62%
ACO-30Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic91.60%83.82%
ACO-31Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)92.98%87.22%
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)82.81%77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.*= Measure required beginning Reporting Year 2015.

N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A